For over 40 years, New England Biolabs, Inc. has led the industry in the discovery and production of molecular biology reagents. In addition to products for genomic research, NEB continues to expand its product offerings into areas related to PCR, gene expression, sample prep for next gen sequencing, cellular analysis, synthetic biology and RNA analysis. NEB is also supporting customers in the development of diagnostics and vaccines for SARS-CoV-2.